IL6R and Sepsis: Given the ongoing development of therapeutics that target trans-specific IL-6 signalling and therapeutics that target CRP itself, this may represent a future avenue in sepsis therapeutics [43,44]; however, this does not alter the interpretation of the primary IL6R blockade-related finding here.